NewsRx

Search our medical news database

Emphysema

A Genetic Disorder Leading To Emphysema Is Unexpectedly Common

Published in Gene Therapy Weekly, June 2nd, 1997

The following was issued by Bayer Corporation, West Haven, Connecticut:

A genetic disorder that can lead to a severe and potentially lethal form of emphysema is surprisingly common, according to a recent report of the World Health Organization (WHO). Based on its estimated gene frequency, the disorder - known as alpha1-antitrypsin deficiency (A1AD) - is one of the most prevalent hereditary disorders among people of Northern European descent. A1AD may affect as many as 100,000 Americans, but only a small number have been diagnosed.

Bayer Corporation is supporting a major new clinical research initiative and a global awareness campaign to address two...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook